amlodipine has been researched along with atenolol in 152 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (1.32) | 18.7374 |
| 1990's | 25 (16.45) | 18.2507 |
| 2000's | 76 (50.00) | 29.6817 |
| 2010's | 36 (23.68) | 24.3611 |
| 2020's | 13 (8.55) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brobyn, R; Brown, RD; Frishman, WH; Johnson, BF; Reeves, RL; Wombolt, DG | 3 |
| Cocco, G; de Bruijn, B; Tyler, HM | 1 |
| Fogari, R; Malamani, GD; Marasi, G; Vanasia, A; Villa, G; Zoppi, A | 1 |
| Bretnall, AE; Clarke, GS | 1 |
| Biscione, F; Lanza, GA; Manzoli, A; Natale, A; Santarelli, P | 1 |
| Davies, RF; Dessain, P; Foris, K; Habibi, H; Herbert, M; Klinke, WP; Lepage, S; Nadeau, C; Phaneuf, DC; Raman, S | 1 |
| Ames, RP; Applegate, WB; Burris, JF; Davidov, ME; Mroczek, WJ; Ram, CV | 1 |
| Channer, KS; Morice, AH; Stewart, AG; Woodmansey, PA | 1 |
| Buttars, JA; Davies, RF; Dessain, P; Habibi, H; Klinke, WP; Lepage, S; Linden, W; Nadeau, C; Phaneuf, DC | 1 |
| Antonios, TF; Cappuccio, FP; MacGregor, GA; Markandu, ND; Sagnella, GA | 1 |
| Mulcahy, D | 1 |
| Dees, A; Derkx, FH; Krijnen, P; Man in't Veld, AJ; Pieterman, H; Postma, CT; Schalekamp, MA; van Jaarsveld, BC; Woittiez, AJ | 1 |
| Agodoa, LY; Glassock, R; Kirk, KA; Kusek, JW; Lee, JY; Randall, OS; Toto, RD; Wright, JT | 1 |
| Cornell, CE; Faulkner, M; Greene, PG; Kopple, JD; Kusek, JW; Lee, JY; Milligan, S; Smith, DE | 1 |
| Chronos, NA; Fox, K; Goodall, AH; Knight, CJ; Panesar, M; Patel, D; Wilson, DJ | 1 |
| Baron, B; Bernaud, C; Hotton, JM; Kahn, JC; Marchand, X; Pathé, M; Rocha, P; Zannier, D | 1 |
| Bernink, PJ; Bouwens, LH; Dunselman, PH; Herweijer, AH; Holwerda, KJ; van Kempen, LH | 1 |
| Fox, KM; Knight, CJ | 1 |
| Bartelink, A; Dees, A; Derkx, F; Krijnen, P; Man in't Veld, A; Schalekamp, M; van Jaarsveld, B | 1 |
| Deedwania, PC; Fakouhi, TD; Frishman, WH; Glasser, S; Johnson, M; Stone, P | 1 |
| Chierchia, SL; Fragasso, G; Margonato, A; Rossetti, E; Xuereb, M; Xuereb, RG | 1 |
| Ford, MD; Kerns, WP; Kline, JA; Tomaszewski, CA; Yuan, TH | 1 |
| Colonna, G; Lanza, GA; Maseri, A; Pasceri, V | 1 |
| Donnan, PT; Lim, PO; MacDonald, TM | 1 |
| Argekar, AP; Powar, SG | 1 |
| Grote, L; Hedner, J; Kraiczi, H; Peker, Y | 1 |
| Anderson, R; Hollenberg, NK; Williams, GH | 1 |
| Chaswal, M; Shankar, N; Singh, S; Tandon, OP | 1 |
| Frishman, W; Glasser, SP; Johnson, MF; Stone, P; White, WB | 1 |
| Ekdahl, S; Karlson, BW; Pehrsson, SK; Persson, S; Ringqvist, I; Ulvenstam, G | 1 |
| Fazzari, L; Mettimano, M; Migneco, A; Pichetti, F; Romano Spica, V; Savi, L; Specchia, L | 1 |
| Deinum, J; Derkx, FH; Krijnen, P; Postma, CT; Schalekamp, MA; van Jaarsveld, BC; Woittiez, AJ | 1 |
| Beevers, G; Caulfield, M; Collins, R; Dahlöf, B; Kjeldsen, SE; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Peuhkurinen, K; Risteli, J; Ruskoaho, H; Tokola, H; Uusimaa, P; Vuolteenaho, O; Ylitalo, A | 1 |
| Nieminen, MS; Oikarinen, L; Toivonen, L; Viitasalo, M | 1 |
| Caulfield, MC; Collier, DJ; Eldridge, S; Feder, GS; Griffiths, CG; Hemingway, H; Kirby, PL; Poulter, NR | 1 |
| Park, JB; Pu, Q; Schiffrin, EL | 1 |
| Beevers, DG; Blann, AD; Gurney, D; Lip, GY; Spencer, CG | 1 |
| Beckerman, B; Brennan, C; Bultas, J; Deanfield, JE; Detry, JM; Lichtlen, PR; Sellier, P; Thaulow, E; Young, ST | 1 |
| Lester, MH; Resnick, LM | 1 |
| Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F | 1 |
| Beevers, DG; Blann, AD; Felmeden, DC; Lip, GY; Spencer, CG | 1 |
| Guy, S; Herity, N; Silke, B; Tham, TC | 1 |
| Chaitman, BR; Chumakova, G; Kuch, J; Parker, JO; Pepine, CJ; Skettino, SL; Skopal, J; Wang, W; Wolff, AA | 1 |
| Jiang, YY; Miao, CY; Shen, FM; Shu, H; Su, DF; Xu, LP | 1 |
| Anderson, A; Bertram, D; Lauri, J; Morgan, T | 1 |
| Jiang, YY; Miao, CY; Shen, FM; Su, DF; Xie, HH; Xu, LP | 1 |
| Gratsianskiĭ, NA | 1 |
| Kulschewski, A; Schrader, J | 1 |
| Ling, G; Shen, FM; Su, DF; Xie, HH; Xu, LP | 1 |
| Baykal, B; Baysan, O; Cincik, M; Kayir, H; Ozkan, M; Ozogul, C; Sag, C; Uzbay, IT; Uzun, M; Yokusoglu, M | 1 |
| Karpov, IuA | 1 |
| Füessl, HS | 1 |
| Bilous, R | 1 |
| Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D | 1 |
| Collier, D; Cruickshank, K; Hughes, AD; Lacy, PS; O'Rourke, M; Stanton, A; Thom, SM; Thurston, H; Williams, B | 1 |
| Colon, P; Crow, R; Cutler, JA; Davis, BR; Dunn, K; Ellsworth, A; Franklin, S; Furberg, C; Goff, D; Golden, J; Leenen, F; Mohiuddin, S; Papademetriou, V; Piller, LB; Proschan, M | 1 |
| Coleman, JJ; Kendall, MJ | 1 |
| Coelho, EB; da Silva, CA; Fazan, R; Nobre, F; Salgado, HC | 1 |
| Kähönen, M; Kööbi, T; Nieminen, T | 1 |
| Dart, AM; Gatzka, CD; Kingwell, B | 1 |
| Cameron, JD; Hope, SA; Meredith, IT | 1 |
| Fournier, A; Safar, ME | 1 |
| Feely, J; Mahmud, A | 1 |
| Chiara Cavallini, M; Palmieri, V; Pini, R | 1 |
| Blann, AD; Felmeden, DC; Lip, GY; Spencer, CG | 1 |
| Ahmed, M; Barman, RK; Hossain, MB; Ibne Wahed, MI; Islam, MA; Islam, R; Khan, A; Rahman, BM | 1 |
| Rahn, KH | 1 |
| Coyne, DW; Nath, V; Zheng, S | 1 |
| Christian, R; Colon, PJ; Cushman, WC; Einhorn, PT; Ford, CE; Goff, DC; Henriquez, MA; Margolis, KL; Piller, LB; Vidt, DG; Wong, ND; Wright, JT | 1 |
| Buxton, M; Dahlöf, B; Jönsson, B; Kahan, T; Lindgren, P; Poulter, NR; Sever, PS; Wedel, H | 2 |
| Cai, GJ; Ling, G; Liu, AJ; Liu, JG; Shen, FM; Su, DF | 1 |
| Dahlof, B; Dobson, J; Gupta, AK; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Aubert, JF; Bouzourene, K; Hayoz, D; Mazzolai, L; Nussberger, J; Pellegrin, M | 1 |
| Baykal, B; Baysan, O; Cincik, M; Kayir, H; Koz, C; Ozkan, M; Ozogul, C; Sag, C; Uzbay, IT; Uzun, M; Yokusoglu, M | 1 |
| Mourad, JJ; Waeber, B | 1 |
| Sundermeyer, M; Veeraputhiran, M | 1 |
| Mehlsen, J | 1 |
| Beevers, G; Caulfield, M; Collins, R; Dahlöf, B; Kjeldsen, SE; Kristinsson, A; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Han, SH; Kim, SJ; Koh, KK; Koh, Y; Lee, Y; Quon, MJ; Shin, EK | 1 |
| Aryal, S; Skalko-Basnet, N | 1 |
| Chen, YY; Han, P; Mehta, JL; Miao, CY; Sassard, J; Shen, FM; Su, DF; Xie, HH | 1 |
| Chang, CL; Dahlof, B; Mastorantonakis, S; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Barrios, V; Escobar, C | 1 |
| Atkins, N; Caulfield, M; Collier, D; Dicker, P; Dolan, E; McInnes, G; O'Brien, E; Stanton, AV; Thom, S | 1 |
| Allemann, S; Chaturvedi, N; Hughes, A; Mayet, J; O'Brien, E; Poulter, N; Sever, P; Stanton, A; Stettler, C; Tapp, R; Thom, S; Witt, N | 1 |
| Bolbrinker, J; Huber, M; Kreutz, R; Scholze, J | 1 |
| Davies, JE; Francis, DP; Hughes, AD; Manisty, CH; Mayet, J; McG Thom, SA; Parker, KH; Zambanini, A | 1 |
| Campbell, NR; Dahlöf, B; Dobson, JE; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Dutta, TK; Madanmohan, T; Pavithran, P; Prakash, ES | 1 |
| Andrushchishina, TB; Morozova, TE | 1 |
| Fiehn, A; Hegde, HV; Puri, GD | 1 |
| Dahlöf, B; Dobson, JE; Dolan, E; Howard, SC; O'Brien, E; Poulter, NR; Rothwell, PM; Sever, PS | 1 |
| Achouba, A; Boutouyrie, P; Laurent, S; Trunet, P | 1 |
| Chaturvedi, N; Hughes, AD; Mayet, J; O'Brien, E; Poulter, NR; Sever, PS; Sharp, A; Stanton, AV; Tapp, RJ; Thom, SA | 1 |
| Cappuccio, FP; Caulfield, M; Collier, D; Cruickshank, JK; Dobson, J; Eldridge, S; Feder, G; Gupta, AK; Poulter, NR; Sever, PS | 1 |
| Del Giaccio, A; Eblen-Zajjur, A | 1 |
| Buch, J; Caulfield, MJ; Collier, DJ; Dahlöf, B; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Hosseini, F; Mahmoudian, M; Nemati, F; Rahbar-Roshandel, N; Shafiei, M | 1 |
| Peuhkurinen, K; Peuhkurinen, S; Risteli, J; Uusimaa, P; Vuolteenaho, O; Ylitalo, A | 1 |
| Chang, CL; Dahlöf, B; Gupta, AK; Nasothimiou, EG; Poulter, NR; Sever, PS | 1 |
| Berwanger, O; Mion Júnior, D; Ortega, KC; Silva, GV; Tsuji, RL | 1 |
| Hotha, KK; Kallem, RR; Mullangi, R; Ravindranath, LK; Seshagirirao, JV; Spoorthy, YN | 1 |
| Bespalova, LD; Kalyuzhin, VV; Kalyuzhina, EV; Kolesnikov, RN; Pushnikova, EY; Teplyakov, AT | 1 |
| Baksi, AJ; Barron, AJ; Fitzgerald, D; Hughes, AD; Jabbour, RJ; Mayet, J; O'Brien, E; Poulter, N; Sever, P; Sharp, A; Stanton, A; Surendran, P; Thom, S | 1 |
| Jeffers, BW; Wang, JG; Yan, P | 1 |
| Lamie, NT | 2 |
| Amjad-Iranagh, S; Goharpey, F; Modarress, H; Yousefpour, A | 2 |
| Cole, JB; Laes, JR; Williams, DM | 1 |
| Kannappan, V; Mannemala, SS | 1 |
| Atkins, E; Bennett, A; Burke, M; Chalmers, J; Chou, M; Chow, CK; Dehbi, HM; Hillis, G; Hilmer, S; Krum, H; Neal, B; Nelson, M; Patel, A; Peiris, D; Reid, CM; Rodgers, A; Rogers, K; Salam, A; Thakkar, J; Thom, S; Usherwood, T; Vo, K; Webster, R; Woodward, M | 1 |
| Paradkar, SG; Sinha, SR | 1 |
| Al-Abassi, FA; Al-Alsieni, AI; Anwar, F; Bacha, AO; Hejazi, MM; Kaleemuddin, M; Kazmi, I | 1 |
| Collier, T; Godec, T; Gupta, A; Mackay, J; Pocock, S; Poulter, N; Sever, P; Whitehouse, A | 1 |
| Beach, JL; Davis, BR; Ishak, A; Juraschek, SP; Mukamal, KJ; Simpson, LM | 1 |
| Beach, JL; Davis, BR; Ishak, A; Juraschek, SP; Mukamal, KJ; Shmerling, RH; Simpson, LM | 1 |
| Del Pinto, R; Ferri, C; Parati, G | 1 |
| Allo, MA; Bertera, FM; Carranza, A; Chiappetta, DA; Del Mauro, JS; Donato, M; Gelpi, RJ; González, GE; Gorzalczany, SB; Höcht, C; Morales, C; Morettón, MA; Polizio, AH; Prince, PD; Santander Plantamura, Y; Taira, CA | 1 |
| Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V | 1 |
| Godec, T; Gupta, AK; Mackay, J; Rostamian, S; Sever, PS; Whitehouse, A; Whiteley, WN | 1 |
| Behera, G; Jayaraman, R; Murugesan, R; Nagaraj, GA; Subramanian, A; Thirunavukarasu, SC | 1 |
| Du, Y; Kan, Z; Ma, M; Zhang, J; Zhang, X | 1 |
| Du, Y; Feng, Z; Gan, J; Li, X; Ma, M; Miao, P; Zhang, J; Zhang, L | 1 |
| Ballotari, M; Gottardo, R; Tagliaro, F; Taus, F; Utzeri, C | 1 |
| Bai, X; Huang, Z; Li, Q; Lin, X; Zhu, Y | 1 |
| Bakker, ENTP; Coolen, BF; de Vos, J; Heijst, JA; Jongenelen, CAM; Naessens, DMP; Richard, E; Scholl, ER; Strijkers, GJ; Teunissen, CE; van der Wel, NN; VanBavel, E; Wilhelmus, MMM | 1 |
| A Wartolowska, K; André, E; Biessels, GJ; Bousser, MG; Dichgans, M; Duering, M; Kerkhofs, D; Kopczak, A; Mansmann, U; Middeke, M; N Doubal, F; Norrving, B; Onkenhout, L; Rothwell, PM; S Stringer, M; Staals, J; Thrippleton, MJ; van den Brink, H; van Dinther, M; van Oostenbrugge, R; W Blair, G; Wardlaw, JM; Webb, AJ | 1 |
| Abd El-Aziz, H; Zeid, AM | 1 |
9 review(s) available for amlodipine and atenolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Blood Pressure; Calcium Channel Blockers; Chronotherapy; Delayed-Action Preparations; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Randomized Controlled Trials as Topic; Retrospective Studies; Verapamil | 2000 |
[Old or new antihypertensives--which are better?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Risk; Risk Factors; Sodium Chloride Symporter Inhibitors; Time Factors | 2005 |
[Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Controlled Clinical Trials as Topic; Enalapril; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Perindopril; Placebos; Risk Factors; Surveys and Questionnaires; Time Factors; Vasodilator Agents; Verapamil | 2005 |
Will ASCOT change the form of anti-hypertensive therapy?
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Lipids; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors | 2006 |
The Anglo-Scandinavian Cardiac Outcomes Trial-- blood pressure lowering arm.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Complications; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 2006 |
Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Enalapril; Humans; Hypertension; Lisinopril; Losartan; Randomized Controlled Trials as Topic | 2014 |
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome | 2017 |
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease; Female; Fetal Growth Retardation; Furosemide; Gestational Age; Humans; Hypertension; Incidence; Infant, Small for Gestational Age; Ketanserin; Methyldopa; Network Meta-Analysis; Nifedipine; Perinatal Death; Pindolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Severity of Illness Index | 2020 |
64 trial(s) available for amlodipine and atenolol
| Article | Year |
|---|---|
A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension.
Topics: Adolescent; Adult; Aged; Amlodipine; Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Pulse | 1992 |
A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension.
Topics: Adolescent; Adult; Aged; Amlodipine; Atenolol; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Nifedipine; Patient Compliance; Random Allocation | 1988 |
Multicenter placebo-controlled comparison of amlodipine and atenolol in mild to moderate hypertension.
Topics: Adult; Aged; Amlodipine; Atenolol; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Random Allocation | 1988 |
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Fibrinogen; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Potassium; Triglycerides; Uric Acid | 1995 |
Electrophysiologic effects of amlodipine vs. diltiazem in patients with coronary artery disease and beta-blocking therapy.
Topics: Adult; Aged; Amlodipine; Atenolol; Coronary Disease; Diltiazem; Drug Therapy, Combination; Electrophysiology; Female; Heart; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia | 1994 |
Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.
Topics: Amlodipine; Atenolol; Cross-Over Studies; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Time Factors | 1995 |
Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension.
Topics: Adolescent; Adult; Aged; Amlodipine; Atenolol; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Double-Blind Method; Drug Combinations; Electrocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pulse; Safety; Single-Blind Method; Triglycerides | 1994 |
Amlodipine in patients with angina uncontrolled by atenolol. A double blind placebo controlled cross over trial.
Topics: Aged; Amlodipine; Angina Pectoris; Atenolol; Blood Pressure; Cardiac Output; Double-Blind Method; Exercise Tolerance; Heart Rate; Humans; Male; Middle Aged; Time Factors | 1993 |
Amlodipine versus atenolol in essential hypertension.
Topics: Adolescent; Adult; Aged; Amlodipine; Atenolol; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Edema; Fatigue; Female; Headache; Heart Rate; Humans; Hypertension; Male; Middle Aged | 1994 |
Relative importance of psychologic traits and severity of ischemia in causing angina during treadmill exercise. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.
Topics: Amlodipine; Angina Pectoris; Atenolol; Exercise Test; Exercise Tolerance; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Psychological Tests; Regression Analysis | 1993 |
A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Treatment Failure | 1996 |
Pointers from recent multicentre trials using ambulatory monitoring--placing placebo in perspective.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Coronary Disease; Drug Therapy, Combination; Electrocardiography, Ambulatory; Humans; Placebo Effect; Vasodilator Agents | 1995 |
'Hypertension resistant to two-drug treatment' is a useful criterion to select patients for angiography: the 'Dutch Renal Artery Stenosis Intervention Cooperative' (DRASTIC) study.
Topics: Adolescent; Adult; Aged; Amlodipine; Angiography; Antihypertensive Agents; Atenolol; Drug Resistance, Multiple; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Patient Selection; Radionuclide Imaging; Renal Artery Obstruction | 1996 |
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black or African American; Blood Pressure; Drug Evaluation; Enalapril; Female; Humans; Hypertension, Renal; Kidney Function Tests; Male; Middle Aged; Multicenter Studies as Topic; Patient Compliance; Patient Selection; Pilot Projects; Quality Control; Quality of Life; Randomized Controlled Trials as Topic; Research Design; Sample Size | 1996 |
Effect of blood pressure control and antihypertensive drug regimen on quality of life: the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.
Topics: Adult; Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Atenolol; Black or African American; Blood Pressure; Enalapril; Female; Humans; Hypertension, Renal; Male; Middle Aged; Multivariate Analysis; Pilot Projects; Prospective Studies; Quality of Life; Research Design | 1996 |
Acute hemodynamic effects of amlodipine 15 days after a myocardial infarction in normotensive patients treated with atenolol.
Topics: Acute Disease; Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction | 1997 |
Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Exercise Tolerance; Female; Humans; Male; Middle Aged; Safety; Treatment Outcome | 1998 |
Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Coronary Angiography; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Safety; Treatment Outcome | 1998 |
The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale, design and inclusion data.
Topics: Adolescent; Adult; Aged; Amlodipine; Angiography; Angioplasty, Balloon; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypertension, Renovascular; Middle Aged; Netherlands; Prognosis; Renal Artery Obstruction; Research Design; Retrospective Studies | 1998 |
Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Middle Aged; Treatment Outcome; Verapamil | 1999 |
Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X.
Topics: Adrenergic beta-Antagonists; Amlodipine; Analysis of Variance; Atenolol; Cross-Over Studies; Double-Blind Method; Female; Humans; Isosorbide Dinitrate; Microvascular Angina; Middle Aged; Statistics, Nonparametric; Treatment Outcome; Vasodilator Agents | 1999 |
Does the Dundee Step Test predict outcome in treated hypertension? A sub-study protocol for the ASCOT trial. Anglo-Scandinavian Cardiac Outcome Trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Diuretics; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Perindopril; Predictive Value of Tests; Survival Rate; Treatment Outcome | 2000 |
Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Single-Blind Method; Sleep Apnea, Obstructive; Sodium Chloride Symporter Inhibitors | 2000 |
Medical therapy, symptoms, and the distress the cause: relation to quality of life in patients with angina pectoris and/or hypertension.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Quality of Life; Treatment Outcome; Verapamil | 2000 |
Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Middle Aged; Nitrates | 2000 |
Combination therapy with beta-adrenergic blockade and amlodipine as second line treatment in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Atenolol; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 2000 |
Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cohort Studies; Drug Resistance; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension, Renal; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radiography; Renal Artery; Renal Artery Obstruction | 2001 |
Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Adult; Amlodipine; Antihypertensive Agents; Arteries; Atenolol; Buttocks; Calcium Channel Blockers; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Reference Values; Vascular Resistance; Vasodilation; Vasodilator Agents | 2002 |
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Cross-Sectional Studies; Electrocardiography; Female; Hematocrit; Hemorheology; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; P-Selectin; Perindopril; Regression Analysis; Single-Blind Method; Treatment Outcome; von Willebrand Factor | 2002 |
Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Isosorbide; Male; Middle Aged; Myocardial Ischemia | 2002 |
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed | 2002 |
A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes T
Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Brachial Artery; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Hemorheology; Humans; Hypercholesterolemia; Hyperemia; Hypertension; Male; Middle Aged; Models, Biological; Risk; Risk Management; Treatment Outcome; Ultrasonography; von Willebrand Factor | 2003 |
Haemodynamic comparison of amlodipine and atenolol in essential hypertension using the quantascope.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Heart Rate; Hemodynamics; Humans; Hypertension; Middle Aged; Stroke Volume; Ultrasonography, Doppler; Vascular Resistance | 1993 |
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Amlodipine; Angina Pectoris; Atenolol; Calcium Channel Blockers; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Physical Exertion; Piperazines; Ranolazine; Survival Analysis | 2004 |
Effect of different antihypertensive drug classes on central aortic pressure.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Aorta; Atenolol; Blood Pressure; Brachial Artery; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Enalapril; Female; Humans; Male; Treatment Outcome | 2004 |
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Propranolol; Ramipril; Transforming Growth Factor beta1 | 2006 |
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Insufficiency; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 2006 |
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Treatment Outcome | 2006 |
Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Calcium Channel Blockers; Capsules; Captopril; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged | 2007 |
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Diuretics; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; P-Selectin; Perindopril; Platelet Activation; United Kingdom; Vascular Resistance; von Willebrand Factor | 2007 |
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Canada; Chlorthalidone; Clonidine; Double-Blind Method; Doxazosin; Female; Heart Diseases; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Puerto Rico; Reserpine; Treatment Outcome; United States; United States Virgin Islands; White People | 2007 |
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease-Free Survival; Drug Costs; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Markov Chains; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Quality-Adjusted Life Years; Smoking; Stroke | 2008 |
Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Diabetic Angiopathies; Drug Therapy, Combination; England; Female; Humans; Hypertension; Male; Middle Aged; Patient Selection; Perindopril; Sweden | 2008 |
Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
Topics: Aged; Amlodipine; Anti-Arrhythmia Agents; Antihypertensive Agents; Atenolol; Atrial Fibrillation; Blood Pressure; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hypertension; Male; Middle Aged; Propafenone; Prospective Studies; Secondary Prevention; Tetrazoles; Valine; Valsartan | 2008 |
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Peripheral Vascular Diseases; Scandinavian and Nordic Countries; Stroke; Thiazides; United Kingdom | 2008 |
Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.
Topics: Adipokines; Adiponectin; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Benzimidazoles; Biphenyl Compounds; Cholesterol, HDL; Comorbidity; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Single-Blind Method; Tetrazoles; Triglycerides | 2010 |
Coronary heart disease benefits from blood pressure and lipid-lowering.
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Blood Pressure; Coronary Disease; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Risk Factors; Risk Reduction Behavior; Sodium Chloride Symporter Inhibitors | 2009 |
Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
Topics: Aged; Amlodipine; Atenolol; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Prospective Studies; Thiazides | 2009 |
Differential effects of antihypertensive treatment on the retinal microcirculation: an anglo-scandinavian cardiac outcomes trial substudy.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Linear Models; Male; Microcirculation; Middle Aged; Multivariate Analysis; Probability; Prospective Studies; Retinal Diseases; Retinal Vessels; Risk Assessment; Scandinavian and Nordic Countries; Severity of Illness Index; Treatment Outcome; United Kingdom | 2009 |
Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjects.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Area Under Curve; Atenolol; Calcium Channel Blockers; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Humans; Imidazoles; Male; Olmesartan Medoxomil; Tetrazoles; Therapeutic Equivalency | 2009 |
Differences in the magnitude of wave reflection account for differential effects of amlodipine- versus atenolol-based regimens on central blood pressure: an Anglo-Scandinavian Cardiac Outcome Trial substudy.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Flow Velocity; Blood Pressure; Brachial Artery; Carotid Arteries; Female; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Pulsatile Flow; Systole; Treatment Outcome | 2009 |
Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Europe; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Proportional Hazards Models; Treatment Outcome | 2009 |
[An experience of the use of a fixed atenolol amlodipine combination in real clinical practice: results of multicenter Russian study].
Topics: Administration, Oral; Adolescent; Adult; Amlodipine; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Treatment Outcome; Young Adult | 2009 |
Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Risk; Stroke | 2010 |
Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Probability; Prospective Studies; Severity of Illness Index; Single-Blind Method; Systole; Tetrazoles; Treatment Outcome; Valine; Valsartan; Young Adult | 2010 |
Cardiovascular drugs in human mechanical nociception: digoxin, amlodipine, propranolol, pindolol and atenolol.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Cardiovascular Diseases; Cross-Sectional Studies; Digoxin; Female; Humans; Male; Middle Aged; Nociceptors; Pindolol; Propranolol; Young Adult | 2010 |
Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).
Topics: Adult; Age Factors; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged | 2011 |
Natriuretic peptides and collagen biomarkers in patients with medical treatment for hypertension.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Biomarkers; Collagen; Collagen Type I; Humans; Hypertension; Natriuretic Peptide, Brain; Peptide Fragments; Peptides; Procollagen; Ventricular Remodeling | 2011 |
Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk.
Topics: Aged; Algorithms; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Diuretics; Drug Resistance; Female; Humans; Hypertension; Ireland; Male; Middle Aged; Perindopril; Risk Factors; Scandinavian and Nordic Countries; United Kingdom | 2011 |
[Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome].
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Amlodipine; Angina, Stable; Atenolol; Calcium Channel Blockers; Coronary Disease; Dose-Response Relationship, Drug; Exercise Tolerance; Humans; Lipids; Male; Metabolic Syndrome; Middle Aged; Quality of Life; Time Factors; Treatment Outcome; Triglycerides | 2013 |
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Drug Therapy, Combination; Echocardiography, Doppler; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Perindopril; Time; Treatment Failure; Ventricular Function, Left; White People | 2014 |
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome | 2017 |
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
Topics: Adult; Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Calcium Channel Blockers; Cardiovascular Diseases; Cause of Death; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Risk Factors; United Kingdom | 2018 |
The EffecTs of Amlodipine and other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases (TREAT-SVDs) trial: Study protocol for a randomised crossover trial.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cross-Over Studies; Humans; Losartan; Prospective Studies; Randomized Controlled Trials as Topic | 2023 |
80 other study(ies) available for amlodipine and atenolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Investigation and optimisation of the use of micellar electrokinetic chromatography for the analysis of six cardiovascular drugs.
Topics: Amlodipine; Atenolol; Cardiovascular Agents; Chromatography; Diltiazem; Electrochemistry; Hydrogen-Ion Concentration; Kinetics; Micelles; Nicardipine; Nifedipine; Osmosis; Sodium Dodecyl Sulfate; Verapamil | 1995 |
Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angina, Unstable; Atenolol; Blood Platelets; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flow Cytometry; Humans; Male; Nitroglycerin; Platelet Activation | 1997 |
Long-term preservation of left ventricular function in medically treated patients with coronary artery disease and persistent exercise-induced ischemia.
Topics: Aged; Amlodipine; Anti-Arrhythmia Agents; Atenolol; Cardiovascular Agents; Coronary Disease; Data Interpretation, Statistical; Diastole; Diltiazem; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Follow-Up Studies; Humans; Middle Aged; Nifedipine; Nitrates; Stroke Volume; Systole; Time Factors; Vasodilator Agents; Ventricular Function, Left | 1999 |
Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning.
Topics: Adolescent; Adult; Amlodipine; Atenolol; Calcium Channel Blockers; Chemotherapy, Adjuvant; Female; Glucose; Hemodynamics; Humans; Insulin; Male; Middle Aged; Suicide, Attempted; Verapamil | 1999 |
Simultaneous determination of atenolol and amlodipine in tablets by high-performance thin-layer chromatography.
Topics: Amlodipine; Atenolol; Calibration; Chromatography, Thin Layer; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tablets | 2000 |
A study of pulmonary profile of hypertensive patients--comparison of atenolol vs amlodipine.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Humans; Hypertension; Total Lung Capacity; Vital Capacity | 1998 |
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Benzothiadiazines; Coronary Disease; Diuretics; Humans; Hypertension; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors | 2001 |
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Bendroflumethiazide; Cardiomegaly; Endothelin-1; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Perindopril; Procollagen; Randomized Controlled Trials as Topic | 2001 |
Comparative effects of atenolol-based and amlodipine-based antihypertensive therapy on QT dispersion in hypertensive subjects.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Electrocardiography; Humans; Hypertension; Hypertrophy, Left Ventricular | 2001 |
Differential response to amlodipine and atenolol mono-therapy for hypertension by ethnic group.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Atenolol; Black or African American; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Ethnicity; Humans; Hypertension; Logistic Models; Male; Multicenter Studies as Topic; Renin; Surveys and Questionnaires; White People | 2001 |
Differential effects of antihypertensive drug therapy on arterial compliance.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Treatment Outcome; Vascular Resistance | 2002 |
Synergism of atenolol and amlodipine on lowering and stabilizing blood pressure in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Amlodipine; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Drug Synergism; Female; Hypertension; Male; Rats; Rats, Inbred SHR | 2004 |
Two useful methods for evaluating antihypertensive drugs in conscious freely moving rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Evaluation, Preclinical; Drug Synergism; Female; Hypertension; Male; Nitrendipine; Rats; Rats, Inbred SHR | 2004 |
[Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. Results of CARISA].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Cardiovascular Agents; Chronic Disease; Diltiazem; Double-Blind Method; Exercise Test; Humans; Multicenter Studies as Topic; Piperazines; Placebos; Randomized Controlled Trials as Topic; Ranolazine; Time Factors; Vasodilator Agents | 2004 |
Synergistic effects of atenolol and amlodipine for lowering and stabilizing blood pressure in 2K1C renovascular hypertensive rats.
Topics: Adrenergic beta-Antagonists; Amlodipine; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Synergism; Heart Rate; Hypertension, Renovascular; Male; Rats; Rats, Sprague-Dawley | 2005 |
[ASCOT-BPLA Study raises new questions regarding: which is the best initial antihypertensive drug?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Atorvastatin; Calcium Channel Blockers; Cardiovascular Diseases; Doxazosin; Drug Therapy, Combination; Follow-Up Studies; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 2005 |
The prevention of myocardial ultrastructural changes by perindopril, atenolol and amlodipine in chronic alcohol administered rats.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Calcium Channel Blockers; Central Nervous System Depressants; Ethanol; Male; Microscopy, Electron; Myocardium; Perindopril; Rats; Rats, Wistar | 2006 |
[Antihypertensive therapy: campaign of the giants].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Survival Analysis | 2005 |
Results of the ASCOT-BPLA trial: no practical implications for treatment of hypertension.
Topics: Amlodipine; Atenolol; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 2006 |
Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2K1C rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Autonomic Nervous System; Blood Pressure; Cardiovascular System; Heart Rate; Hydrochlorothiazide; Hypertension; Losartan; Male; Ramipril; Rats; Rats, Wistar; Sympathetic Nervous System | 2006 |
Letter by Nieminen et al regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study".
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Heart Rate; Humans; Hypertension; Reproducibility of Results; Stroke Volume | 2006 |
Letter by Dart et al regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study".
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Endpoint Determination; Female; Heart Rate; Humans; Hypertension; Male; Predictive Value of Tests; Stroke Volume; Treatment Outcome | 2006 |
Letter by Cameron et al regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study".
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Heart Rate; Humans; Hypertension; Proportional Hazards Models; Stroke Volume; Treatment Outcome | 2006 |
Letter by Safar and Fournier regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study".
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Heart Rate; Humans; Hypertension; Indapamide; Perindopril; Proportional Hazards Models; Reproducibility of Results; Stroke Volume; Treatment Outcome | 2006 |
Ivabradine: new drug. Best avoided in stable angina.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Benzazepines; Calcium Channel Blockers; Cost-Benefit Analysis; Drug Approval; Europe; Humans; Randomized Controlled Trials as Topic; Verapamil | 2007 |
Pulsology reloaded: commentary on similar effects of treatment on central and brachial blood pressure in older hypertensive subjects.
Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Losartan; Manometry; Perindopril; Ultrasonography, Doppler | 2007 |
Simultaneous high-performance liquid chromatographic determination of atenolol and amlodipine in pharmaceutical-dosage form.
Topics: Amlodipine; Analysis of Variance; Antihypertensive Agents; Atenolol; Chromatography, High Pressure Liquid; Drug Combinations; Reproducibility of Results; Tablets | 2007 |
[Treating essential hypertension. Are beta blockers still first choice?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Multicenter Studies as Topic; Myocardial Infarction; Outcome Assessment, Health Care; Perindopril; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Stroke | 2007 |
ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Kidney Diseases; Male; Middle Aged; Pilot Projects; Renal Dialysis; Severity of Illness Index; Treatment Outcome | 2007 |
Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously hypertensive rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Synergism; Drug Therapy, Combination; Female; Male; Rats; Rats, Inbred SHR; Stroke; Survival Rate | 2007 |
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.
Topics: Amides; Amlodipine; Animals; Antihypertensive Agents; Apolipoproteins E; Atenolol; Atherosclerosis; Biphenyl Compounds; Blood Pressure; Cholesterol; Disease Models, Animal; Disease Progression; Female; Fumarates; Heart Rate; Irbesartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Renin; Renin-Angiotensin System; Tetrazoles | 2008 |
Perindopril, atenolol, and amlodipine prevent aortic ultrastructural changes in rats exposed to ethanol.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Atenolol; Calcium Channel Blockers; Endothelial Cells; Ethanol; Male; Microscopy, Electron; Perindopril; Rats; Rats, Wistar | 2008 |
Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Double-Blind Method; Drug Therapy, Combination; France; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Losartan; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.
Topics: Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Azetidines; Carcinoma, Non-Small-Cell Lung; Coronary Artery Disease; Drug Interactions; Erlotinib Hydrochloride; Ezetimibe; Female; Humans; Hyperlipidemias; Hypertension; Lung Neoplasms; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Quinazolines; Rhabdomyolysis; Simvastatin; Tomography, X-Ray Computed | 2008 |
[Hypertension--does it matter how blood pressure is lowered?].
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Bendroflumethiazide; Cardiovascular Diseases; Cost-Benefit Analysis; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Treatment Outcome | 2008 |
Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
Topics: Aluminum; Amlodipine; Atenolol; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Compounding; Drug Packaging; Drug Stability; Excipients; Humidity; Polyvinyl Chloride; Reproducibility of Results; Tablets; Technology, Pharmaceutical; Temperature | 2008 |
The combination of atenolol and amlodipine is better than their monotherapy for preventing end-organ damage in different types of hypertension in rats.
Topics: Amlodipine; Animals; Atenolol; Blood Pressure; Drug Therapy, Combination; Hemodynamics; Hypertension; Male; Organ Specificity; Rats; Rats, Sprague-Dawley; Regression Analysis; Time Factors | 2009 |
Diabetes and hypertension: which is the best approach?
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic | 2009 |
The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Atorvastatin; Calcium Channel Blockers; Cardiovascular Diseases; Cost-Benefit Analysis; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Models, Economic; Pyrroles; Scandinavian and Nordic Countries; Treatment Outcome | 2009 |
Effect of antihypertensive drug therapy on short-term heart rate variability in newly diagnosed essential hypertension.
Topics: Adult; Amlodipine; Antihypertensive Agents; Arrhythmia, Sinus; Atenolol; Enalapril; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sinoatrial Node | 2010 |
An unusual phenomenon with entropy during induction of general anaesthesia.
Topics: Adrenergic beta-Antagonists; Amlodipine; Anesthesia, General; Anesthetics, Intravenous; Antihypertensive Agents; Atenolol; Cholecystectomy; Electroencephalography; Entropy; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Monitoring, Intraoperative; Propofol | 2010 |
Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Diastole; Echocardiography, Doppler; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Ventricular Function, Left | 2010 |
Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.
Topics: Age Factors; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Confounding Factors, Epidemiologic; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Racial Groups; Randomized Controlled Trials as Topic; Sex Factors; Treatment Outcome | 2010 |
What your blood pressure isn't revealing.
Topics: Adrenergic beta-Antagonists; American Heart Association; Amlodipine; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Coronary Disease; Diagnosis, Differential; Diastole; Diet, Sodium-Restricted; Humans; Hypertension; Myocardial Infarction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Systole; Time Factors; United States | 2010 |
Anti-inflammatory effects of anti-hypertensive agents: influence on interleukin-1β secretion by peripheral blood polymorphonuclear leukocytes from patients with essential hypertension.
Topics: Adult; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Atenolol; Captopril; Case-Control Studies; Female; Humans; Hydrochlorothiazide; Hypertension; In Vitro Techniques; Inflammation Mediators; Interleukin-1beta; Lipopolysaccharides; Losartan; Male; Middle Aged; Neutrophils | 2011 |
An economic evaluation of antihypertensive therapies based on clinical trials.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Costs; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Randomized Controlled Trials as Topic | 2012 |
I take three different blood pressure medications-six pills total-every day. They are isosorbide mononitrate, amlodipine, and atenolol. They seem to do a good job bringing down my blood pressure, but before my 6 p.m. atenolol and then later before my 10 p
Topics: Amlodipine; Atenolol; Blood Pressure; Blood Pressure Determination; Circadian Rhythm; Drug Administration Schedule; Health Status; Humans; Hypertension; Isosorbide Dinitrate; Vasodilator Agents | 2011 |
Simultaneous estimation of amlodipine and atenolol in human plasma: a sensitive LC-MS/MS method validation and its application to a clinical PK study.
Topics: Adrenergic beta-1 Receptor Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chromatography, Liquid; Humans; Male; Sensitivity and Specificity; Tandem Mass Spectrometry | 2013 |
Simultaneous determination of binary mixture of amlodipine besylate and atenolol based on dual wavelengths.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Drug Combinations; Limit of Detection; Spectrophotometry; Tablets | 2015 |
Interaction of PEGylated anti-hypertensive drugs, amlodipine, atenolol and lisinopril with lipid bilayer membrane: A molecular dynamics simulation study.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Diffusion; Dimyristoylphosphatidylcholine; Energy Transfer; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Lisinopril; Molecular Dynamics Simulation; Molecular Structure; Polyethylene Glycols; Software; Static Electricity; Structure-Activity Relationship; Time Factors; Water | 2015 |
Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report.
Topics: Amlodipine; Atenolol; Hemodynamics; Humans; Male; Methylene Blue; Middle Aged; Shock; Valsartan; Vasodilation | 2015 |
Simultaneous enantioseparation and purity determination of chiral switches of amlodipine and atenolol by liquid chromatography.
Topics: Amlodipine; Atenolol; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Contamination; Stereoisomerism | 2016 |
Spectrophotometric Methods for Simultaneous Determination of Amlodipine Besylate and Atenolol in Their Tablet Dosage Form.
Topics: Amlodipine; Atenolol; Calibration; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry; Tablets | 2015 |
Combination of anti-hypertensive drugs: a molecular dynamics simulation study.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Dimyristoylphosphatidylcholine; Humans; Hydrogen Bonding; Hypertension; Lipid Bilayers; Lisinopril; Molecular Conformation; Molecular Dynamics Simulation; Software; Water | 2017 |
Drug utilization among hypertensive patients in the outpatient department of medicine in a tertiary care hospital: A cross-sectional study.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Cross-Sectional Studies; Drug Prescriptions; Drug Utilization; Enalapril; Female; Guideline Adherence; Humans; Hypertension; Internal Medicine; Male; Middle Aged; Outpatient Clinics, Hospital; Polypharmacy; Practice Guidelines as Topic; Practice Patterns, Physicians'; Tertiary Care Centers | 2018 |
Alteration of serum immunoglobins, C-reactive protein, vitamin D, and electrolyte by atenolol and amlodipine in stress-induced hypertensive rats.
Topics: Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Atenolol; C-Reactive Protein; Calcium; Electrolytes; Female; Hypertension; Immunoglobulin G; Immunoglobulin M; Male; Potassium; Rats, Wistar; Sodium; Stress, Physiological; Vitamin D | 2018 |
Effects of Antihypertensive Class on Falls, Syncope, and Orthostatic Hypotension in Older Adults: The ALLHAT Trial.
Topics: Accidental Falls; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Atenolol; Chlorthalidone; Female; Humans; Hypertension; Hypotension, Orthostatic; Incidence; Male; Medicare; Syncope; Treatment Outcome; United States | 2019 |
The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Female; Gout; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Treatment Outcome | 2020 |
Reduction of blood pressure variability: an additional protective cardiovascular effect of vasodilating beta-blockers?
Topics: Adrenergic beta-Antagonists; Amlodipine; Animals; Atenolol; Blood Pressure; Rats; Rats, Inbred SHR | 2020 |
Effects of third-generation β-blockers, atenolol or amlodipine on blood pressure variability and target organ damage in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Amlodipine; Animals; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Cytokines; Heart Ventricles; Rats; Rats, Inbred SHR | 2020 |
Long-Term Incidence of Stroke and Dementia in ASCOT.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Cholesterol; Dementia; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Risk Factors; Scandinavian and Nordic Countries; Stroke; Treatment Outcome; United Kingdom | 2021 |
Effect of Blood Pressure Reduction on Intraocular Pressure and Ophthalmic Artery Blood Flow Velocity in Hypertension.
Topics: Amlodipine; Atenolol; Blood Flow Velocity; Blood Pressure; Humans; Hypertension; Intraocular Pressure; Ophthalmic Artery; Prospective Studies | 2022 |
Zeolitic imidazolate framework-67-modified open-tubular column with cyclodextrin for enantioseparation in capillary electrochromatography.
Topics: Amlodipine; Atenolol; Capillary Electrochromatography; Cyclodextrins; Histidine; Metoprolol; Propranolol; Stereoisomerism; Zeolites | 2022 |
Carboxymethyl-β-cyclodextrin and histidine-zeolitic imidazolate framework-8 used for enantioseparation of three basic drugs in open-tubular capillary electrochromatography.
Topics: Amlodipine; Atenolol; beta-Cyclodextrins; Capillary Electrochromatography; Histidine; Propranolol; Stereoisomerism; Zeolites | 2022 |
Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium; Calcium Channel Blockers; Chromatography, Liquid; Hair Analysis; Humans; Labetalol; Metoprolol; Nadolol; Nebivolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry | 2022 |
A super-hydrophilic partially reduced graphene oxide membrane with improved stability and antibacterial properties.
Topics: Amlodipine; Anti-Bacterial Agents; Atenolol; Calcium Chloride; Carbamazepine; Chlorides; Graphite; Hydrophobic and Hydrophilic Interactions; Ibuprofen; Membranes, Artificial; Pharmaceutical Preparations; Piperazines; Polyphenols; Salts; Sodium Chloride; Tea; Water | 2022 |
Effect of long-term antihypertensive treatment on cerebrovascular structure and function in hypertensive rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Atenolol; Carotid Artery, Common; Hypertension; Hypotension; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2023 |
Derivatization-free conventional and synchronous spectrofluorimetric estimation of atenolol and amlodipine.
Topics: Amlodipine; Atenolol; Humans; Pharmaceutical Preparations; Spectrometry, Fluorescence | 2024 |